Accurate and reliable bioanalytical data are critical to the success of drug, biologic, and device development programs. At MED Institute, we offer a full spectrum of bioanalytical services, including the development, validation, and execution of assays for quantification of drugs, biomarkers, and impurities in biological matrices. Our state-of-the-art laboratories and experienced scientific staff ensure that your studies meet regulatory requirements for GLP/GCP compliance. Whether you need support for pharmacokinetic, pharmacodynamic, or immunogenicity studies, we deliver high-quality data and regulatory-ready reports to support IND, NDA, BLA, or 510(k) submissions. Our extensive expertise includes:
OUR COMMITMENT
We are committed to consistently performing services with high quality, that deliver exceptional results, and add value to the client’s business.
For client surveys sent in 2024, we received ratings of 4.98/5 points (13).